SMEAR-ULM detects early melanoma
Analysis based on 6 articles · First reported May 25, 2026 · Last updated Jun 08, 2026
The development of SMEAR-ULM by the Institut national de la recherche scientifique and Université de Montréal could significantly impact the biotechnology and healthcare sectors by introducing a non-invasive, early detection method for melanoma. This innovation has the potential to reduce healthcare costs associated with biopsies and improve patient outcomes, leading to increased investment and growth opportunities in medical diagnostics.
Scientists from the Institut national de la recherche scientifique and Université de Montréal have developed SMEAR-ULM, a high-tech system for early detection of skin cancer. Led by INRS professor Jinyang Liang, the technology uses a temporary 'intelligent tattoo' of nanoparticles to measure subtle temperature variations caused by cancer cells. This non-invasive method, successfully tested on mice, can detect micro-melanomas as early as four days old, a stage typically missed by conventional imaging. The findings, published in Nature Sensors, promise to reduce unnecessary biopsies, improve diagnostic accuracy, and support clinical decision-making, with potential applications beyond skin cancer detection.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard